Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia...
18 insider purchases on record · latest filing 2025-12-30.
Insiders have also filed 3 sale transactions at FBRX.